Biocon is among the companies that gave a good performance in 2016 and the stock surged 80 percent this year. Speaking to CNBC-TV18, Kiran Mazumdar Shaw, CMD of the company, said the company has gained traction in many emerging markets with its biosimilars.
first published: Dec 22, 2016 12:02 pm
A collection of the most-viewed Moneycontrol videos.
Nifty Tests 25,900 But Stages Smart Recovery From Day's Low | Closing Bell Live | 4K
The Bihar conundrum- freebies Vs Growth with NK Singh, Economist and Former MP
Will Nifty Cross 26,100 Hurdle On Weekly F&O Expiry? PhysicsWallah Lists Today|Opening Bell Live
How SIP Top-Ups Can Boost Your Wealth | Smart Investing Made Simple
